EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms

Douwe F de Wit, Coco M Fuhri Snethlage, Johannes H M Levels, Elena Rampanelli, Abraham S Meijnikman, Max Nieuwdorp, Nordin M J Hanssen

Diabetologia · 2026

DOI: 10.1007/s00125-026-06829-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2026. Verfasst von Douwe F de Wit und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands. d.f.dewit@amsterdamumc.nl. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Feces, Pancreatic Elastase, Exocrine Pancreatic Insufficiency. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DON - DNF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Although exocrine pancreatic insufficiency (EPI) is thought to be common in type 1 diabetes, little is known about the relationship of EPI with type 1 diabetes parameters or food intake and abdominal complaints. Characterising individuals with EPI could help prevent EPI-related complications such as malabsorption and osteoporosis.

Methods

In a cross-sectional cohort of 443 individuals with type 1 diabetes (62% female, median age 42 years [IQR 29–54], mean BMI 25±4 kg/m 2 , median diabetes duration 16 years [IQR 6–29]), we associated faecal elastase (FE) levels, as a marker of EPI, with type 1 diabetes parameters and clinical features, using linear and Poisson regression models.

Results

The mean FE level (±SD) was 349.5±146.8 µg/g faeces. A number of variables were independently associated with lower FE levels: older age (−10.97 µg/g faeces per 10 years; 95% CI −21.02, −0.92), longer diabetes duration (−13.09 µg/g per 10 years; 95% CI −23.54, −2.64), higher HbA 1c (−1.44 mmol/mol per 1 SD increase in FE levels, 95% CI −2.59, −0.30), male sex (−54.07 µg/g; 95% CI −81.41, −26.73) and smoking (−85.06 µg/g; 95% CI −128.52, −41.60). In a linear analysis, we found no evidence of associations between FE levels and markers of residual beta cell function, liver disease, macronutrient intakes or gastrointestinal complaints. Using a cut-off of 200 µg/g faeces, 76 individuals (17%) were found to have EPI, which was associated with a 4.31 mmol/mol (0.39%) higher HbA 1c (95% CI 1.35, 7.26), an 8% higher mean glucose (95% CI 2, 14), a 9% lower fibre intake (95% CI 1, 17) and an 8% lower energy intake (95% CI 1, 15). Conclusions/interpretation The lack of evidence for associations with clinical parameters in this relatively healthy population of individuals with type 1 diabetes does not support the use of FE for routine screening for EPI. However, the high prevalence of low FE levels and their association with lower food intake and higher glucose levels justify a need for clinical awareness for EPI and its complications, especially in individuals with long diabetes duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1FecesPancreatic ElastaseExocrine Pancreatic InsufficiencyEatingHumansFemaleMaleAdultCross-Sectional StudiesMiddle AgedPrevalence

Stichwörter der Autor:innen

Clinical scienceEpidemiologyGastro-entero pancreatic factors

Substanzen

Pancreatic Elastase

Autor:innen und Institutionen

  • Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands. d.f.dewit@amsterdamumc.nl.
  • Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam, the Netherlands. d.f.dewit@amsterdamumc.nl.
  • Department of Experimental Vascular Medicine, Amsterdam UMC, Amsterdam, the Netherlands.
  • Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam, the Netherlands.
  • Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, the Netherlands.
  • The Netherlands Diabeter Centrum Amsterdam, Amsterdam, the Netherlands.

Förderung

  • DON - DNF

Zitieren

APA

de Wit, D. F., Fuhri Snethlage, C. M., Levels, J. H. M., Rampanelli, E., Meijnikman, A. S., Nieuwdorp, M., & Hanssen, N. M. J. (2026). High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms. Diabetologia. https://doi.org/10.1007/s00125-026-06829-9

Vancouver

de Wit DF, Fuhri Snethlage CM, Levels JHM, Rampanelli E, Meijnikman AS, Nieuwdorp M, et al. High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms. Diabetologia. 2026. doi:10.1007/s00125-026-06829-9

BibTeX
@article{deWit2026,
  author = {de Wit, Douwe F and Fuhri Snethlage, Coco M and Levels, Johannes H M and Rampanelli, Elena and Meijnikman, Abraham S and Nieuwdorp, Max and Hanssen, Nordin M J},
  title = {High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms},
  journal = {Diabetologia},
  year = {2026},
  doi = {10.1007/s00125-026-06829-9}
}
Kostenlos starten →